Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

24.13
-0.2600-1.07%
Volume:451.71K
Turnover:11.17M
Market Cap:1.90B
PE:-13.36
High:25.17
Open:24.36
Low:24.13
Close:24.39
52wk High:36.26
52wk Low:2.86
Shares:78.66M
Float Shares:53.14M
Volume Ratio:0.62
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8064
EPS(LYR):-2.2041
ROE:-59.22%
ROA:-34.41%
PB:6.17
PE(LYR):-10.95

Loading ...

Olema Pharmaceuticals Chief Discovery Officer David C. Myles Reports Disposal of Common Shares

Reuters
·
Jan 15

Olema Highlights Palazestrant Strategy in New Investor Presentation

TIPRANKS
·
Jan 13

Assessing Olema Pharmaceuticals (OLMA) Valuation After Analyst Upgrades And Recent Fundraising

Simply Wall St.
·
Jan 11

Olema Pharmaceuticals Inc : UBS Initiates Coverage With Buy Rating and Target Price $45

THOMSON REUTERS
·
Jan 07

Olema Pharmaceuticals Initiated at Overweight by Piper Sandler

Dow Jones
·
Jan 07

Piper Sandler Initiates Olema Pharmaceuticals at Overweight With $40 Price Target

MT Newswires Live
·
Jan 07

BRIEF-Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jan 06

Olema Pharmaceuticals Grants Stock Options to Eight New Employees Under Inducement Plan

Reuters
·
Jan 06

Director Cyrus Harmon Reports Sale of Olema Pharmaceuticals Common Shares

Reuters
·
Dec 30, 2025

Olema Pharmaceuticals Chief Discovery Officer David C. Myles Reports Disposal of Common Shares

Reuters
·
Dec 24, 2025

Olema Pharmaceuticals Is Maintained at Buy by Citigroup

Dow Jones
·
Dec 12, 2025

Olema Pharmaceuticals Inc Files for Mixed Shelf - SEC Filing

THOMSON REUTERS
·
Dec 12, 2025

Olema Pharmaceuticals: Sales Agreement Prospectus Covering Offering of up to $200 Mln Common Stock That May Be Issued From Time to Time

THOMSON REUTERS
·
Dec 12, 2025

Olema Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 11, 2025

Biopharmaceutical Firm Olema Pharmaceuticals, Inc. Surges Over 32% in Pre-Market Trading

Deep News
·
Dec 10, 2025

Olema Pharmaceuticals Grants Stock Options to New Employees Under Inducement Plan

Reuters
·
Dec 03, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Dec 03, 2025

Olema Pharmaceuticals (OLMA): Assessing Valuation Following $190 Million Equity Offering and Underwriter Changes

Simply Wall St.
·
Nov 28, 2025

Olema Pharmaceuticals to Join Evercore Healthcare Conference

Reuters
·
Nov 22, 2025

Olema Pharmaceuticals Is Maintained at Buy by Goldman Sachs

Dow Jones
·
Nov 22, 2025